Unknown

Dataset Information

0

Structural Insight into the Mechanism of 4-Aminoquinolines Selectivity for the alpha2A-Adrenoceptor.


ABSTRACT: Background:?2A-adrenoceptor (AR) is a potential target for the treatment of degenerative diseases of the central nervous system, and ?2A-AR agonists are effective drugs for this condition. However, the lack of high selectivity for ?2A-AR subtype of traditional drugs greatly limits their clinic usage. Methods:A series of homobivalent 4-aminoquinolines conjugated by two 4-aminoquinoline moieties via varying alkane linker length (C2-C12) were characterized for their affinities for each ?2-AR subtype. Subsequently, docking, molecular dynamics and mutagenesis were applied to uncover the molecular mechanism. Results:Most 4-aminoquinolines (4-aminoquinoline monomer, C2-C6, C8-C10) were selective for ?2A-AR over ?2B- and ?2C-ARs. Besides, the affinities are of similar linker length-dependence for each ?2-AR subtype. Among all the compounds tested, C10 has the highest affinity for ?2A-AR (pKi=-7.45±0.62), which is 12-fold and 60-fold selective over ?2B-AR and ?2C-AR, respectively. Docking and molecular dynamics suggest that C10 simultaneously interacts with orthosteric and "allosteric" sites of the ?2A-AR. The mutation of F205 decreases the affinity by 2-fold. The potential allosteric residues include S90, N93, E94 and W99. Conclusion:The specificity of C10 for the ?2A-AR and the potential orthosteric and allosteric binding sites proposed in this study provide valuable guidance for the development of novel ?2A-AR subtype selective compounds.

SUBMITTER: Li Z 

PROVIDER: S-EPMC7340475 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural Insight into the Mechanism of 4-Aminoquinolines Selectivity for the alpha2A-Adrenoceptor.

Li Zaibing Z   Li Jingyu J   Liu Liyan L   Deng Wenyi W   Liu Qingrong Q   Liu Ruofan R   Zhang Wen W   He Zaiqing Z   Fan Lei L   Yang Yingzhuo Y   Duan Yun Y   Hou Huifang H   Wang Xinyuan X   Yang Zhimei Z   Wang Xiaoying X   Chen Shanze S   Wang Yi Y   Huang Ning N   Chen Junli J  

Drug design, development and therapy 20200703


<h4>Background</h4>α<sub>2A</sub>-adrenoceptor (AR) is a potential target for the treatment of degenerative diseases of the central nervous system, and α<sub>2A</sub>-AR agonists are effective drugs for this condition. However, the lack of high selectivity for α<sub>2A</sub>-AR subtype of traditional drugs greatly limits their clinic usage.<h4>Methods</h4>A series of homobivalent 4-aminoquinolines conjugated by two 4-aminoquinoline moieties via varying alkane linker length (C2-C12) were characte  ...[more]

Similar Datasets

| S-EPMC3307019 | biostudies-literature
| S-EPMC9132230 | biostudies-literature
| S-EPMC2815116 | biostudies-literature
| S-EPMC4776285 | biostudies-literature
| S-EPMC9579193 | biostudies-literature
| S-EPMC5727383 | biostudies-literature
| S-EPMC4593101 | biostudies-literature
| S-EPMC5714064 | biostudies-literature
| S-EPMC5785972 | biostudies-literature
| S-EPMC8701324 | biostudies-literature